These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20162259)

  • 1. Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture.
    Huntjens KM; Kosar S; van Geel TA; Geusens PP; Willems P; Kessels A; Winkens B; Brink P; van Helden S
    Osteoporos Int; 2010 Dec; 21(12):2075-82. PubMed ID: 20162259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures.
    Huntjens KM; van Geel TC; Geusens PP; Winkens B; Willems P; van den Bergh J; Brink PR; van Helden S
    Injury; 2011 Sep; 42 Suppl 4():S39-43. PubMed ID: 21939802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality.
    Huntjens KM; van Geel TA; van Helden S; van den Bergh J; Willems P; Winkens B; Geusens PP; Brink PR
    BMC Musculoskelet Disord; 2013 Apr; 14():121. PubMed ID: 23557115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture liaison services: do they reduce fracture rates?
    de Bruin IJA; Wyers CE; van den Bergh JPW; Geusens PPMM
    Ther Adv Musculoskelet Dis; 2017 Jul; 9(7):157-164. PubMed ID: 28717402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.
    Hasserius R; Karlsson MK; Nilsson BE; Redlund-Johnell I; Johnell O;
    Osteoporos Int; 2003 Jan; 14(1):61-8. PubMed ID: 12577186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.
    Muschitz C; Kocijan R; Baierl A; Dormann R; Feichtinger X; Haschka J; Szivak M; Muschitz GK; Schanda J; Pietschmann P; Resch H; Dimai HP
    Osteoporos Int; 2017 May; 28(5):1609-1618. PubMed ID: 28138718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.
    Bliuc D; Nguyen ND; Milch VE; Nguyen TV; Eisman JA; Center JR
    JAMA; 2009 Feb; 301(5):513-21. PubMed ID: 19190316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between mortality risk and the number, location, and sequence of subsequent fractures in the elderly.
    Lee SB; Park Y; Kim DW; Kwon JW; Ha JW; Yang JH; Lee BH; Suk KS; Moon SH; Kim HS; Lee HM
    Osteoporos Int; 2021 Feb; 32(2):233-241. PubMed ID: 32820370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial.
    Schwartz AV; Bauer DC; Cummings SR; Cauley JA; Ensrud KE; Palermo L; Wallace RB; Hochberg MC; Feldstein AC; Lombardi A; Black DM;
    J Bone Miner Res; 2010 May; 25(5):976-82. PubMed ID: 20200926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing non-vertebral fracture risk reduction with osteoporosis therapies: looking beneath the surface.
    Sebba A
    Osteoporos Int; 2009 May; 20(5):675-86. PubMed ID: 19052831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of new clinical fractures within 2 years following a fracture.
    van Helden S; Cals J; Kessels F; Brink P; Dinant GJ; Geusens P
    Osteoporos Int; 2006; 17(3):348-54. PubMed ID: 16378167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival times of patients with a first hip fracture with and without subsequent major long-bone fractures.
    Angthong C; Angthong W; Harnroongroj T; Naito M; Harnroongroj T
    J Nippon Med Sch; 2013; 80(1):42-9. PubMed ID: 23470805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of short term fracture risk in patients with a recent history of low-trauma non-vertebral fracture.
    Deloumeau A; Moltó A; Roux C; Briot K
    Bone; 2017 Dec; 105():287-291. PubMed ID: 28842362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study.
    Alarkawi D; Bliuc D; Tran T; Ahmed LA; Emaus N; Bjørnerem A; Jørgensen L; Christoffersen T; Eisman JA; Center JR
    Osteoporos Int; 2020 Jan; 31(1):119-130. PubMed ID: 31654084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: The Rotterdam Study.
    Trajanoska K; Schoufour JD; de Jonge EAL; Kieboom BCT; Mulder M; Stricker BH; Voortman T; Uitterlinden AG; Oei EHG; Ikram MA; Zillikens MC; Rivadeneira F; Oei L
    Bone; 2018 Sep; 114():116-124. PubMed ID: 29885926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies.
    Langdahl BL; Silverman S; Fujiwara S; Saag K; Napoli N; Soen S; Enomoto H; Melby TE; Disch DP; Marin F; Krege JH
    Bone; 2018 Nov; 116():58-66. PubMed ID: 30021126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies.
    Harris ST; Blumentals WA; Miller PD
    Curr Med Res Opin; 2008 Jan; 24(1):237-45. PubMed ID: 18047776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year refracture rates of a province-wide fracture liaison service.
    Sujic R; Beaton DE; Mamdani M; Cadarette SM; Luo J; Jaglal S; Sale JEM; Jain R; Bogoch E;
    Osteoporos Int; 2019 Aug; 30(8):1671-1677. PubMed ID: 31152183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.